fluorodeoxyglucose f18 has been researched along with ifosfamide in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Handa, M; Hirai, S; Ihaya, A; Imamura, Y; Kawabe, M; Morioka, K; Sasaki, K; Shinoda, T; Tanabe, S; Tanaka, K; Uesaka, T; Yamada, N | 1 |
| Chawla, SP; Conti, PS; Fedenko, A; Iagaru, A; Masamed, R; Menendez, LR | 1 |
| Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Ho, AD; Kasper, B; Strauss, LG | 1 |
| Alinari, L; Baccarani, M; Derenzini, E; Fanti, S; Gandolfi, L; Musuraca, G; Stefoni, V; Tani, M; Venturini, F; Zinzani, PL | 1 |
| Fujimoto, T; Hamada, K; Hashimoto, N; Hatazawa, J; Inoue, A; Myoui, A; Tomita, Y; Yoshikawa, H | 1 |
| Allen-Auerbach, MS; Benz, MR; Chow, K; Czernin, J; Dry, SM; Eckardt, JJ; Eilber, FC; Elashoff, D; Evilevitch, V; Phelps, ME; Tap, WD; Weber, WA | 1 |
| Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P | 1 |
| Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Kasper, B; Schmitt, T; Strauss, LG; Vasamiliette, J | 1 |
| Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Kasper, B; Lehner, B; Mechtersheimer, G; Schmitt, T; Strauss, LG; Stroebel, P; Vasamiliette, J | 1 |
| Botteri, E; Calabrese, L; Cocorocchio, E; Martinelli, G; Peccatori, F; Piperno, G; Preda, L; Travaini, L; Vanazzi, A | 1 |
| Chan, WK; Huang, B; Khong, PL; Kwong, YL; Lee, EY | 1 |
| Arranz, R; Bargay, J; Bello, JL; Caballero, MD; Conde, E; Coronado, M; González-Barca, E; Grande, C; Hernández, MT; Marín-Niebla, A; Martín, A; Montes-Moreno, S; Panizo, C; Pardal, E; Pérez-Ceballos, E | 1 |
| Advani, RH; Gascoyne, R; Habermann, TM; Hong, F; Horning, SJ; Kahl, BS; Li, H; Quon, A; Ranheim, EA; Swinnen, LJ | 1 |
| Butcher, B; Chong, G; Cull, G; Fay, K; Filshie, R; Gandhi, MK; Gill, D; Grigg, A; Hahn, U; Hertzberg, M; Hicks, RJ; Ho, SJ; Hofman, MS; Johnston, A; Kannourakis, G; Lewis, ID; Milliken, S; Renwick, W; Seymour, JF; Taper, J; Trotman, J; Warburton, P; Watson, AM; Wirth, A | 1 |
| Chen, G; Liao, JQ; Liu, ET; Wang, SX; Wang, SY; Xie, L | 1 |
| Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A | 1 |
| Allen, PB; Bazzi, LA; Bryan, LJ; Casulo, C; Chmiel, JS; Dillehay, GL; Gordon, LI; Kane, KL; Karmali, R; Mehta, J; Palmer, BA; Pro, B; Savas, H; Smith, SE; Winter, JN | 1 |
1 review(s) available for fluorodeoxyglucose f18 and ifosfamide
| Article | Year |
|---|---|
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2019 |
10 trial(s) available for fluorodeoxyglucose f18 and ifosfamide
| Article | Year |
|---|---|
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 2008 |
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Vincristine | 2008 |
Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2009 |
Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis.
Topics: Discriminant Analysis; Doxorubicin; Drug Therapy, Combination; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Metastasis; Patient Selection; Positron-Emission Tomography; Risk; Sarcoma; Survival Analysis; Treatment Outcome | 2010 |
Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Discriminant Analysis; Doxorubicin; Etoposide; Feasibility Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ifosfamide; Neoadjuvant Therapy; Patient Selection; Radionuclide Imaging; Risk; Sarcoma; Time Factors; Treatment Outcome | 2010 |
Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Transplantation, Autologous; Treatment Outcome; Vincristine | 2014 |
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prospective Studies; Rituximab; Vincristine; Young Adult | 2015 |
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Positron-Emission Tomography; Prednisone; Retreatment; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2017 |
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ifosfamide; Male; Positron Emission Tomography Computed Tomography; Salvage Therapy | 2023 |
6 other study(ies) available for fluorodeoxyglucose f18 and ifosfamide
| Article | Year |
|---|---|
[Yolk sac tumor of the anterior mediastinum and pulmonary metastases; report of a case].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lung Neoplasms; Mediastinal Neoplasms; Positron-Emission Tomography; Superior Vena Cava Syndrome | 2005 |
F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Deoxycytidine; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Young Adult | 2009 |
High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gemcitabine; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methylprednisolone; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2013 |
FDG-PET/CT of invasive thymoma extending into the superior vena cava and right atrium.
Topics: Aged; Cisplatin; Fluorodeoxyglucose F18; Heart Atria; Humans; Ifosfamide; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Thymoma; Thymus Neoplasms; Vena Cava, Superior | 2019 |